Drug recall · April 12, 2023
Montelukast Sodium Oral Granules USP recall
Why: Failed Impurities/Degradation Specifications: failed impurities for Sulphoxide and Impurity A.
Class III: unlikely to cause harm, but breaks the rules (for example a labeling error).
The recall
- Product
Montelukast Sodium Oral Granules USP, 4 mg, packaged in a carton containing 30 packets, Rx only, Distributed By: Teva Pharmaceuticals USA, Inc., Parsippany, NJ 07054, Carton NDC 0093-7487-56, Packet NDC 0093-7487-19
- Lots / codes
Lot # 3007556A, Exp 5/2023
- Quantity
- 3,772 cartons
- Company
- Teva Pharmaceuticals USA Inc, Parsippany, NJ
- Distribution
- USA Nationwide
- Initiated
- March 27, 2023 · Voluntary: Firm initiated
- Classified
- April 6, 2023
- Reported
- April 12, 2023
- Ended
- August 23, 2023
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Montelukast
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.